N/A
N=49
Pudendal Nerve Block for Hemorrhoidectomy
Hemorrhoids · Postoperative Pain
Bottom Line
View on ClinicalTrials.gov: NCT04251884 ↗Enrolled (actual)
49
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcome: Primary: Postoperative Pain on the Visual Analogue Scale (VAS) — 1.4; 3.1 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Local anesthetic (ropivacaine) (Procedure)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Francesco Mongelli
- Primary completion
- Dec 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postoperative Pain on the Visual Analogue Scale (VAS) |
2.8; 4.6; 3.4; 4.7; 1.0; 2.1 | — |
| SECONDARY Postoperative Pain on the Visual Analogue Scale (VAS) |
2.8; 4.6; 3.4; 4.7; 1.0; 2.1 | — |
| SECONDARY Opioids Consumption |
5; 10 | — |
| SECONDARY Lenght of Hospital Stay |
1.2; 1.8 | — |
| SECONDARY Complications Related to the Pudendal Nerve Block |
0; 0 | — |
| SECONDARY Direct and Indirect Cost Analysis in Out- and In-patients |
— | — |
Summary
Patients undergoing Milligan-Morgan hemorrhoidectomy will be randomized to receive or not the pudendal nerve block after the spinal anesthesia.
Eligibility Criteria
Inclusion criteria
- Patients affected by haemorrhoids (grade III and IV) and treated with Milligan-Morgan hemorrhoidectomy under spinal anaesthesia
- Signed informed consent
Exclusion criteria
- Age < 18 years old
- Pregnancy
- Allergy to local anaesthetics
Data sourced from ClinicalTrials.gov (NCT04251884). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.